Evolving Care Across the Cancer Spectrum: The Latest Update in Colorectal Cancer

Friday, March 21, 2025, 7:30 AM - 2:30 PM, Volney Richmond Auditorium, Seattle, WA

Virginia Mason Franciscan Health is a recognized leader across the spectrum of colorectal cancer care. This symposium aims to present important considerations in individualizing care across the cancer care continuum, with a focus on the increasing incidence of young-onset colorectal cancer. Topics include unique risk factors in the role of the microbiome and genetics in colorectal cancer development, fertility considerations and the latest in screening options.

Our midday session will focus on important contemporary debates in colorectal cancer, and an application in a multidisciplinary tumor board context. Lastly, we will focus on managing treatment-related comorbidities and the nuances of continued surveillance.

The overall objective of the course is to demonstrate the benefits of contemporary, personalized care — nuanced decision making, latest trials, and individualized care as offered at a Center of Excellence.

Teaching methods include lecture, Q&A with faculty, case presentation and case discussion.

1. Discuss epidemiologic trends related to young age of onset colorectal cancer
2. Describe how specific intratumoral bacteria are associated with immune changes in the tumor microenvironment
3. Explore the emerging hereditary and environmental explanations in early onset colon cancers
4. Outline fertility preservation options available for colorectal cancer patients
5. Review consensus guidelines for anal cancer screening: who, how, when and why
6. Summarize guidelines suggesting TME-first approach in stage 1 rectal cancer
7. Explain the treatment and follow-up protocols for organ preservation
8. Discuss latest data on neoadjuvant chemotherapy for colon cancer
9. Identify scenarios in which up front surgery avoids over treatment with chemotherapy
10. Develop a framework for patient centered decision making in RT management decisions
11. Describe scenarios in which radiation can be avoided in locally advanced rectal cancer
12. Formulate anticoagulation plans based on current evidence, balancing risks, benefits, and patient preferences
13. Review endoscopic surveillance for colon cancer screening
14. Explain how MRI is the optimal modality for evaluation of extramural venous invasion (EMVI)
15. Assess the risk, diagnosis, and management of hepatotoxicity of chemotherapy and immunotherapy for CRC

ONLINE REGISTRATION IS CLOSED. FOR QUESTIONS AND INFORMATION CONTACT THE CME DEPARTMENT AT [email protected]

Register to attend this course in person or participate via livestream:

$160.00 - Attend in person, includes box lunch.

$135.00 - Attend via Livestream - link will be provided.

Online registration will be open through Wednesday, March 19, 2025. For registration assistance, call the CME department at 206.341.0142 or email [email protected].

The Virginia Mason Medical Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Virginia Mason Medical Center designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Parking: Parking is not included with registration. Virginia Mason's downtown parking facilities are limited and reserved for patients, therefore we offer this map of public lots with walking routes to the Lindeman Pavilion.

Seattle Public transportation: Metro Bus routes serving the First Hill neighborhood include 2, 10, 12, 60, 193, and 303. Please consult the Metro Trip Planner for route information and schedules.

AMA PRA Category 1 Credit(s)™ (5.25 hours), Non-Physician Attendance (5.25 hours)

Mitigation of Relevant Financial Relationships

Virginia Mason Medical Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, March 21, 2025